Quarterly report pursuant to Section 13 or 15(d)

Net Income (Loss) Per Share

v3.19.1
Net Income (Loss) Per Share
3 Months Ended
Mar. 31, 2019
Earnings Per Share [Abstract]  
Net Income (Loss) Per Share

11. Net Income (Loss) per Share

 

The Company accounts for and discloses net income (loss) per common share in accordance with FASB ASC Topic 260, Earnings Per Share. Basic income (loss) per common share is computed by dividing income (loss) attributable to common stockholders by the weighted average number of common shares outstanding. Diluted net income (loss) per common share is computed by dividing net income (loss) attributable to common stockholders by the weighted average number of common shares that would have been outstanding during the period assuming the issuance of common stock for all potential dilutive common shares outstanding. Potential common shares consist of shares issuable upon the exercise of stock options and warrants and the conversion of convertible notes payable.

 

The following table sets forth the computation of basic and diluted net income (loss) per common share (in thousands, except per share amounts) for the three months ended:

 

    March 31, 2019     March 31, 2018  
Numerator:                
Net income (loss) attributable to common stockholders   $ 2,971     $ (1,553 )
                 
Denominator:                
Weighted average number of shares outstanding, basic     30,337       24,384  
Adjustment for dilutive effects of warrants, outstanding and in-the-money     26       -  
Adjustment for dilutive effects of options, exercisable and in-the-money     8       -  
Weighted average number of common shares outstanding, diluted     30,371       24,384  
                 
Net income (loss) per common share, basic   $ 0.10     $ (0.06 )
Net income (loss) per common share, diluted   $ 0.10     $ (0.06 )

 

The following table sets forth the number of potential common shares excluded from the calculations of net loss per diluted share because their inclusion would be anti-dilutive (in thousands):

 

    March 31,  
    2019     2018  
Outstanding options to purchase common stock     1,200       426  
Warrants to purchase common stock     217       209  
Notes payable convertible to common stock     -       247  
Total     1,417       882